Stem cell study for Hypoxic Ischemic Encephalopathy

To evaluate the efficacy of up to two infusions of autologous umbilical cord blood in a prospective, randomized, double-blind, placebo controlled multi-center study.

July 03, 2017

  • Clinical Trial Information

    Trial Contact: Smith, Denise; Sernulka, Kristine

    Trial Phone: 321.841.7816 ; 321.841.3685

  • Age Group: Neonate

    Phase: Not applicable

    Principal Investigator: Jose A. Perez, MD

    Sub Investigators: Gregor C. Alexander, MD;

    IRB No: 16.037.03

    Secondary Protocol No:

    Applicable Disease Sites: Moderate to Severe Hypoxic Ischemic Encephalopathy